News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,390 Results
Type
Article (85695)
Company Profile (747)
Press Release (746948)
Section
Business (232292)
Career Advice (4108)
Deals (39653)
Drug Delivery (120)
Drug Development (90705)
Employer Resources (194)
FDA (17988)
Job Trends (17275)
News (395670)
Policy (39631)
Tag
Academia (2975)
Alliances (56524)
Alzheimer's disease (1358)
Approvals (17897)
Artificial intelligence (177)
Bankruptcy (394)
Best Places to Work (12551)
Biotechnology (512)
Breast cancer (179)
Cancer (1386)
Cardiovascular disease (120)
Career advice (3514)
Cell therapy (308)
Clinical research (71873)
Collaboration (480)
Compensation (253)
COVID-19 (2810)
C-suite (119)
Data (1377)
Diabetes (178)
Diagnostics (6710)
Earnings (94798)
Employer resources (167)
Events (127258)
Executive appointments (376)
FDA (18644)
Funding (434)
Gene therapy (219)
GLP-1 (710)
Government (5053)
Healthcare (20735)
Infectious disease (2907)
Inflammatory bowel disease (124)
Interviews (807)
IPO (17618)
Job creations (5180)
Job search strategy (2855)
Layoffs (492)
Legal (10048)
Lung cancer (204)
Manufacturing (222)
Medical device (14446)
Medtech (14451)
Mergers & acquisitions (22129)
Metabolic disorders (499)
Neuroscience (1704)
NextGen Class of 2024 (7658)
Non-profit (5067)
Northern California (1667)
Obesity (287)
Opinion (245)
Patents (123)
People (64301)
Pharmaceutical (152)
Phase I (22137)
Phase II (31210)
Phase III (23530)
Pipeline (512)
Postmarket research (3547)
Preclinical (10002)
Radiopharmaceuticals (259)
Rare diseases (276)
Real estate (7373)
Regulatory (26060)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1460)
Startups (4276)
United States (15805)
Vaccines (663)
Weight loss (228)
Date
Today (221)
Last 7 days (711)
Last 30 days (3172)
Last 365 days (38337)
2024 (37056)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (230)
Asia (49452)
Australia (8712)
California (3868)
Canada (1409)
China (303)
Colorado (177)
Connecticut (190)
Europe (113252)
Florida (523)
Georgia (139)
Illinois (447)
Indiana (235)
Maryland (669)
Massachusetts (3108)
Michigan (188)
Minnesota (310)
New Jersey (1108)
New York (1085)
North Carolina (871)
Northern California (1667)
Ohio (154)
Pennsylvania (922)
South America (1647)
Southern California (1460)
Texas (568)
Utah (112)
Washington State (426)
There are 833,390 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer
December 11, 2024
·
11 min read
Press Releases
Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies
December 11, 2024
·
7 min read
Press Releases
Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
December 11, 2024
·
5 min read
Press Releases
Lilly’s Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
December 11, 2024
·
26 min read
Press Releases
Aphios Awarded NIH SBIR Grant For Development of Anti-CCR5 Nanoparticles to Treat Alzheimer’s Disease
December 11, 2024
·
1 min read
Press Releases
Adams Clinical Announces Expansion into Inpatient Psychiatry and Schizophrenia Clinical Trial Capabilities with Signing of Partnership with InSite Clinical Research
December 11, 2024
·
4 min read
Press Releases
MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
December 11, 2024
·
1 min read
Press Releases
AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET
December 11, 2024
·
2 min read
Press Releases
OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®
December 11, 2024
·
6 min read
Press Releases
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025
December 11, 2024
·
12 min read
1 of 83,339
Next
